Código QR (código de barras bidimensional)

A randomized, double‐blind, single‐dose study to assess bioequivalence of MB02 biosimilar after manufacturing iteration and reference bevacizumab

Abstract To investigate and compare the pharmacokinetic (PK) profiles of MB02 products, before and after optimizing the manufacturing process, and reference bevacizumab to establish bioequivalence between them. In this randomized, double‐blind, single dose, parallel study, 114 healthy male volunteer...

תיאור מלא

שמור ב:
Principais autores: C. Schwabe, A. Cole, A. Espigares‐Correa, M. E. Beydon, A. Florez‐Igual, J. Queiruga‐Parada
פורמט: Artigo
שפה:Inglês
יצא לאור: Wiley 2023-04-01
סדרה:Pharmacology Research & Perspectives
נושאים:
bevacizumab
biosimilar
clinical trial
MB02
pharmacokinetics
safety
גישה מקוונת:https://doi.org/10.1002/prp2.1070
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים